RT @BlueprintMeds: We plan to present data for RET-altered cancers at #ASCO20, and systemic #mastocytosis at #EHA25 and #EAACI2020: https:/…
RT @BlueprintMeds: We plan to present data for RET-altered cancers at #ASCO20, and systemic #mastocytosis at #EHA25 and #EAACI2020: https:/…
© Nextech Invest Ltd. | privacy policy